Twyneo Approval Shakes up Acne Treatment World

Video

Joshua Zeichner, MD, associate professor of dermatology and director of cosmetic & clinical research in dermatology, Mount Sinai Hospital, New York, discusses the impact of the recent FDA approval of Twyneo (Sol-Gel) for the treatment of acne.

Related Videos
Related Content

Abeona Submits Biologics License Application to FDA for EB-101

September 26th 2023

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

September 23rd 2021

Research Finds Dermatology Visits for Acne Higher in Adult Female Patients

September 21st 2023

The Cutaneous Connection: Episode 30- Impact of the JAK Inhibitor Approval Delays

September 2nd 2021

Clear It Up Like a Derm Campaign Educates Consumers on Acne

September 17th 2023

Maximize Device Options for Acne and Acne Scarring

September 14th 2023

Abeona Submits Biologics License Application to FDA for EB-101

September 26th 2023

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

September 23rd 2021

Research Finds Dermatology Visits for Acne Higher in Adult Female Patients

September 21st 2023

The Cutaneous Connection: Episode 30- Impact of the JAK Inhibitor Approval Delays

September 2nd 2021

Clear It Up Like a Derm Campaign Educates Consumers on Acne

September 17th 2023

Maximize Device Options for Acne and Acne Scarring

September 14th 2023

Abeona Submits Biologics License Application to FDA for EB-101

September 26th 2023

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

September 23rd 2021

Research Finds Dermatology Visits for Acne Higher in Adult Female Patients

September 21st 2023

The Cutaneous Connection: Episode 30- Impact of the JAK Inhibitor Approval Delays

September 2nd 2021

Clear It Up Like a Derm Campaign Educates Consumers on Acne

September 17th 2023

Maximize Device Options for Acne and Acne Scarring

September 14th 2023
© 2023 MJH Life Sciences

All rights reserved.